Semaglutide vs. Tirzepatide: How the Two Weight-Loss Medications Compare

Semaglutide and tirzepatide are both injectable medications in the GLP-1 family that are FDA-approved for weight management, but they work slightly differently. Tirzepatide acts on two hormone pathways instead of one, and in head-to-head research it has shown a modest edge for weight loss. Even so, the better option is individual, because response and side effects vary from person to person. This guide breaks down how they compare on mechanism, results, side effects, and cost. Reviewed by Dr. Yousef Maita, D.O., board-certified in Internal Medicine and lead physician for Dynasty Health's Weight Loss division.

Two GLP-1 Medications, Two Brand Families

One of the first sources of confusion is the brand names, so it helps to sort them out. Semaglutide is sold as Wegovy for weight management and as Ozempic for type 2 diabetes (there is also an oral form, Rybelsus). Tirzepatide is sold as Zepbound for weight management and as Mounjaro for type 2 diabetes. According to the Cleveland Clinic, both are GLP-1 medications approved by the FDA for both diabetes and weight management, but they differ in how they work and how they are dosed.

How They Work: GLP-1 vs. Dual Agonist

Both medications are based on incretin hormones, which your body releases when you eat to help regulate blood sugar and appetite. Semaglutide mimics one of these hormones, GLP-1, which prompts insulin release, slows stomach emptying, and signals fullness to the brain.

Tirzepatide goes a step further as a dual agonist: it activates GLP-1 and a second incretin hormone called GIP. In practical terms, semaglutide works on one pathway while tirzepatide works on two. Both can improve blood sugar and A1C, increase insulin sensitivity, reduce appetite, and support weight loss. One practical difference is dosing form: semaglutide is available as a weekly injection or a daily pill, while tirzepatide is currently a weekly injection only.

Semaglutide vs. Tirzepatide for Weight Loss

This is the comparison most people care about, and it is where tirzepatide tends to stand out. The Cleveland Clinic notes that in head-to-head trials, tirzepatide showed a slight edge over semaglutide for both weight loss and glucose-lowering, and that real-world experience often mirrors this, with some patients losing more weight after switching from semaglutide to tirzepatide. These findings come from the clinical trial programs behind each drug, sometimes referenced as the SURMOUNT and SURPASS studies.

Two caveats keep this honest. First, some comparisons did not use the highest available dose of semaglutide, which can affect the results. Second, and more importantly, response varies significantly from person to person; the medication that produces more weight loss on average is not guaranteed to be the better fit for you. Results are individual and never guaranteed.

What's the Difference Between Ozempic and Mounjaro?

Since these two brand names come up constantly, here is the quick distinction: Ozempic is semaglutide, and Mounjaro is tirzepatide, and both are the versions FDA-approved for type 2 diabetes rather than for weight management. The weight-management versions of the same two drugs are Wegovy (semaglutide) and Zepbound (tirzepatide). So "Ozempic vs. Mounjaro" is essentially the same underlying comparison as semaglutide vs. tirzepatide, just under the diabetes brand names. A physician prescribes based on the FDA-approved indication and your specific situation.

Side Effects: How They Compare

The two medications share a similar side-effect profile. The most common effects are digestive, including nausea, vomiting, diarrhea, constipation, abdominal pain, and heartburn, and these are often reduced by starting at a low dose and increasing gradually, a process called titration. Some people also experience fatigue or headaches, and there is a risk of low blood sugar when these drugs are combined with certain diabetes medications.

Both semaglutide and tirzepatide carry an FDA boxed warning, the strongest type of warning, regarding a risk of thyroid C-cell tumors, and they are not appropriate for people with a personal or family history of certain thyroid cancers. Neither is recommended during pregnancy, and they may be unsuitable for people with severe gastroparesis. This is a central reason these medications require physician oversight.

Should You Switch From Semaglutide to Tirzepatide?

Some people do switch and experience additional weight loss, as the Cleveland Clinic describes, but switching is a medical decision rather than a do-it-yourself one. Whether it makes sense depends on how you have responded, how well you tolerate side effects, your medical history, and practical factors like insurance coverage and availability. Switching also means restarting the titration process at a lower dose. If you are considering a change, that conversation belongs with your prescriber.

Which GLP-1 Is Best for Weight Loss?

There is no single best medication for everyone. Tirzepatide has an edge in average results, but the right choice comes down to your individual response, your tolerance of side effects, your health history, and access. Both are intended as long-term treatments paired with nutrition and physical activity, not quick fixes, and stopping either one can lead to weight regain without those lifestyle foundations, a principle echoed by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). That is why a physician-supervised program matters: through Dynasty Health's metabolic weight-loss program, the medication is chosen and managed as part of a complete plan. You can also read more about how GLP-1 medications work, and anyone weighing medical weight loss in Phoenix can start with an evaluation.

Get a Personalized Recommendation

Choosing between semaglutide and tirzepatide is best done with a physician who can weigh your health, your goals, and your response. Whether you are searching for semaglutide near me, comparing GLP-1 options in Phoenix, or exploring weight loss injections in Phoenix, a medical weight loss consultation in Phoenix is the place to start. Schedule a consultation with Dynasty Health to discuss which option fits you.

Disclaimer: This content is for educational and informational purposes only and does not constitute medical advice. Semaglutide and tirzepatide are prescribed based on their FDA-approved indications and individual medical evaluation. Weight-loss results vary and are not guaranteed, and both medications carry potential side effects and contraindications, including a boxed warning regarding thyroid C-cell tumors. A consultation is required to determine appropriateness. Clinical references are attributed to Cleveland Clinic and NIDDK. Reviewed by Dr. Yousef Maita, D.O.

‍